Dr. Ronit Bendori joined Evergreen in mid 2000 as a General Partner. She focuses on Evergreen's investments in the healthcare sector. Dr. Bendori is a former Vice President and QA/QC Director of Pharmos Ltd. (NASDAQ: PARS). 

Prior to that  Dr. Bendori held senior positions as an expert in technology transfer at InterPharm Ltd. (Israel) and Ares-Serono (Switzerland). As one of its most experienced figures, Dr. Bendori is an active promoter of Israeli health care industry. 

She was one of the founders of the Israeli Biotechnology Organization (IBO), and an adviser to the former Chief Scientists at the Israeli Ministry of Industry and Trade on biotechnology issues. Currently, she is a member of the National Committee for Biotechnology and a member of the advisory board of the Israeli Scientific American.  Dr. Bendori has taught biotechnology in various institutions, including the Israeli Center for Management and Weizmann Institute of Science. She has a Ph.D in molecular and cellular biology from the Weizmann Institute of Science. Dr. Bendorirepresents Evergreen on the boards of Procognia, Transpharma, Quantomix, CorAssist and Neurosonix.